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Pancreas developmentEndothelial cells are required to initiate pancreas development from the endoderm. They also control the
function of endocrine islets after birth. Here we investigate in developing pancreas how the endothelial cells
become organized during branching morphogenesis and how their development affects pancreatic cell
differentiation. We show that endothelial cells closely surround the epithelial bud at the onset of pancreas
morphogenesis. During branching morphogenesis, the endothelial cells become preferentially located near
the central (trunk) epithelial cells and remain at a distance from the branch tips where acinar cells
differentiate. This correlates with predominant expression of the angiogenic factor vascular endothelial
growth factor-A (VEGF-A) in trunk cells. In vivo ablation of VEGF-A expression by pancreas-speciﬁc
inactivation of ﬂoxed Vegfa alleles results in reduced endothelial development and in excessive acinar
differentiation. On the contrary, acinar differentiation is repressed when endothelial cells are recruited
around tip cells that overexpress VEGF-A. Treatment of embryonic day 12.5 explants with VEGF-A or with
VEGF receptor antagonists conﬁrms that acinar development is tightly controlled by endothelial cells. We
also provide evidence that endothelial cells repress the expression of Ptf1a, a transcription factor essential for
acinar differentiation, and stimulate the expression of Hey-1 and Hey-2, two repressors of Ptf1a activity. In
explants, we provide evidence that VEGF-A signaling is required, but not sufﬁcient, to induce endocrine
differentiation. In conclusion, our data suggest that, in developing pancreas, epithelial production of VEGF-A
determines the spatial organization of endothelial cells which, in turn, limit acinar differentiation of the
epithelium.vain, de Duve Institute, Avenue
2 764 75 07.
. Lemaigre).
creas_development.php
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Pancreas development in the mouse starts with the formation of
tissue buds from the ventral and dorsal midgut endoderm. At this
initial stage, the pancreas contains epithelial progenitor cells that will
give rise to exocrine, endocrine and ductal cells, according to a
developmental program tightly regulated by cell autonomous factors
and by interactions with the mesenchyme (Cano et al., 2007; Gittes,
2009; Jorgensen et al., 2007; Murtaugh, 2007). At the onset of
pancreas morphogenesis, i.e. around embryonic day (e) e10.5–e11.5,
the epithelial progenitors are organized as a compact mass of non-polarized cells. Microlumina then appear and coalesce to generate the
lumen of a branched network of ducts, lined by a single-layered
polarized epithelium (Hick et al., 2009; Kesavan et al., 2009; Puri and
Hebrok, 2007).
The epithelial cells located at the tip of the branched ducts initially
consist of multipotent progenitors. These “tip cells” are characterized
by the expression of the transcription factors pancreatic and duodenal
homeobox factor-1 (Pdx1), pancreas-speciﬁc transcription factor
subunit 1a (Ptf1a)/p48 and c-Myc and of the enzyme carboxypepti-
dase A (CPA) (Zhou et al., 2007). The tip cells divide and give rise, on
one hand, to epithelial outgrowths that differentiate to exocrine acini,
and, on the other hand, to the trunks of the branched ducts, from
which endocrine and duct cells differentiate. Exocrine differentiation
is dependent on the transcription factor Ptf1a, which associates with
recombining binding protein suppressor of hairless (RBP)-J and RBP-
JL and stimulates transcription of acinar-speciﬁc genes. The latter
include amylase, which serves as a marker that distinguishes tip cells
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(Exdpf), which in Zebraﬁsh is essential for exocrine development
(Beres et al., 2006; Cockell et al., 1989; Fujikura et al., 2007; Jiang et al.,
2008; Krapp et al., 1998; Masui et al., 2007). Mist1, another basic
helix–loop–helix factor, is required for acinar maturation and control
of exocrine cell proliferation (Jia et al., 2008; Pin et al., 2001; Rukstalis
et al., 2003). There is evidence for a role of the Wnt/β-catenin
pathway in exocrine differentiation (Murtaugh et al., 2005), and
several studies addressing the function of this pathway underscored
the role of β-catenin in acinar cell proliferation, mostly by stimulating
expression of Myc, a factor required for exocrine development (Bonal
et al., 2009; Dessimoz et al., 2005; Heiser et al., 2006; Nakhai et al.,
2008; Papadopoulou and Edlund, 2005 ; Strom et al., 2007; Wells
et al., 2007). Whereas homolog of hairy/enhancer of Split-1 (Hes-1),
an effector of Notch signaling, is not required for exocrine differen-
tiation, sustained Notch signaling activity in the pancreatic epithelium
prevents exocrine differentiation (Hald et al., 2003; Jensen et al.,
2000; Murtaugh et al., 2003). Indeed, the Notch target genes (Hes-1,
Hey-1 and Hey-2) repress Ptf1a activity, independently of changes in
the levels of Ptf1a component proteins (Esni et al., 2004). Moreover,
activation of the Notch pathway is necessary in endocrine progenitors
to sequester RBP-J so as to avoid differentiation of endocrine
progenitors into acinar cells (Cras-Meneur et al., 2009). Conversely,
the pancreatic mesenchyme promotes exocrine differentiation at the
expense of endocrine development (Crisera et al., 2000; Duvillie et al.,
2006; Li et al., 2004; Miralles et al., 1998).
Endothelial cells were shown to play a role at an early stage of
pancreas development. Around e8.75–e9.5 in the mouse embryo, the
aorta and vitelline veins are located near the dorsal and ventral
pancreatic buds, respectively. In vitro recombination of endoderm and
dorsal aorta from e8.25 to e8.5 mouse embryos induces expression of
Pdx-1 and insulin in the endoderm (Lammert et al., 2001). Moreover,
in vivo, aortic endothelial cells are required for maintenance of Pdx1
expression, for induction of Ptf1a and for dorsal pancreas budding
(Yoshitomi and Zaret, 2004). This further implies a relay pathway in
which endothelial cells promote survival of the dorsal pancreatic
mesenchymal cells, the latter being a source of secreted factors, such
as ﬁbroblast growth factor (FGF)-10, that are required for mainte-
nance of Ptf1a expression in the dorsal pancreatic bud (Jacquemin
et al., 2006). Tissue recombination experiments demonstrate that the
endothelial cells can control early pancreas development irrespective
of the presence of blood ﬂow. However, data suggest that sphingosine
1-phosphate, a blood-borne factor, stimulates pancreatic mesen-
chyme proliferation and so promotes pancreas budding from the
endoderm (Edsbagge et al., 2005).
Beyond the stage of pancreas speciﬁcation and tissue budding
from the endoderm, endothelial cells keep an important function in
pancreas differentiation and morphogenesis. Xenopus embryos in
which the aorta has been removed fail to express proendocrine genes
and insulin (Lammert et al., 2001). In the mouse, overexpression of
vascular endothelial growth factor-A (VEGF-A) under control of a
Pdx1 promoter induces hypervascularization in the pancreas. At
2 months of age, this is associated with hyperplasia of the endocrine
islets, and with reduced acini area, suggesting that vascularization can
promote endocrine development at the expense of acinar cells
(Lammert et al., 2001). In the postnatal period, endothelial cells and
endocrine cells mutually support each other: endocrine cells secrete
VEGF-A and endothelial cells produce laminins, which stimulate
insulin gene expression and beta cell proliferation (Lammert et al.,
2003; Nikolova et al., 2006).
It is presently unknown how blood vessels develop in the pancreas
and if blood vessel morphogenesis impacts on the initiation of
pancreatic differentiation. To address these questions, we ﬁrst
provided a detailed description of blood vessel localization in the
pancreas. We further studied pancreatic explants and transgenic
mouse models in which endothelial cell development is eitherstimulated or inhibited by modulation of VEGF-A signaling. Our
results show that VEGF-A expression dictates endothelial cell
localization near epithelial trunk cells, and that endothelial develop-
ment limits acinar differentiation.
Materials and methods
Plasmid
Ptf1a5'enh/Ela1p-Vegfa, used to generate transgenic embryos,
was obtained by replacing the elastase promoter and lacZ gene from
Ptf1a5'enh/Ela1p-nlslacZ (gift from R. MacDonald) (Masui et al.,
2008) by an elastase promoter casette (EcoRV/ClaI) and the Vegfa
insert (ClaI/NheI).
Animals
Vegfa-ﬂoxed mice were obtained from N. Ferrara (Genentech)
(Gerber et al., 1999), Pdx1-green ﬂuorescent protein (Pdx1-GFP) and
Pdx1-Cre from D. Melton (Gu et al., 2002). Transgenic embryos were
generated as described (Poll et al., 2006), with 5 ng/μl of puriﬁed
Ptf1a/ela1p-VEGF-A fragment (XbaI–PacI). All other mice were of the
CD1 strain. The animals were raised and treated according to the
principles of laboratory animal care of the University Animal Welfare
Committee.
Dissection and culture of pancreatic explants
Pancreatic explants were microdissected from e12.5 mouse
embryos and cultured on microporous membranes on M199 medium
supplemented with 10% fetal calf serum (van Eyll et al., 2004). The
medium was changed every day. Recombinant mouse VEGF164 (R&D
systems, Lille, France) was dissolved to 50 μg/ml (stock solution) in
phosphate-buffered saline (PBS) containing 0.5% bovine serum
albumin and added at the ﬁnal concentration of 150 to 500 ng/ml.
SU5416 (VEGFR2 kinase inhibitor III, Calbiochem/VWR, Leuven,
Belgium) was dissolved in dimethyl sulfoxide to 10 mM (stock
solution) and was added at 5 μM in the culture medium. Oxindole I
(Calbiochem/VWR, Leuven, Belgium) was dissolved in DMSO to
50 mM (stock solution) and added at 2 μM in the culture medium.
Control explants were exposed to the same concentration of vehicle
as the test samples.
In situ hybridization
Mouse embryos were ﬁxed overnight at 4 °C in 60% ethanol, 30%
formaldehyde and 10% acetic acid before parafﬁn embedding.
Digoxigenin-labeled antisense RNA probes for Vegfa and VEGF
Receptor type 2/Fetal liver kinase 1 (Vegfr2/Flk1), were produced
by in vitro transcription of the Vegfa and Vegfr2 cDNAs. Speciﬁcally,
probes spanning nucleotides 94 to 429 of the mouse coding sequence
for VEGF and nucleotides 3361 to 4440 of the mouse coding sequence
for VEGFR2 were used. In situ hybridizations were performed on 16-
μm-thick sections as described (Jacquemin et al., 2003). Images were
acquired using a Zeiss Mirax Midi ﬂuorescence microscope.
Immunolabeling and quantiﬁcation
For whole-mount immunolocalization pancreata dissected from
embryos were ﬁxed in 4% formaldehyde in PBS for 2 h at 4 °C and
treated as described (Pierreux et al., 2006). For immunohistochem-
istry after in situ hybridization, sections were treated as described
(Gaide Chevronnay et al., 2008). For immunoﬂuorescence on sections,
embryos or explants were ﬁxed, embedded and processed as
described (Pierreux et al., 2006). Antibodies and dilutions used in
this study are described in Supplementary Table 1. The TSA
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bis-benzimide (Sigma, Bornem, Belgium) or with TOPRO in PBS during
incubation with the secondary antibodies. Fluorescence was observed
with a Zeiss Axiovert 200 inverted ﬂuorescence microscope, with a
Biorad 1024 confocal microscope or with a Zeiss LSM510multiphoton
confocal microscope. Three-dimensional projections were obtained
with the LSM510 software. For quantiﬁcation of Ptf1a-, Paired
Homeobox factor-6 (Pax6)- or Neurogenin-3 (Ngn3)-expressing
cells, the number of positive cells on every sixth sections of
the whole explants was counted. Approximately twenty-ﬁve 7-μm-
sections, each separated by 42 μm, were analysed. Integration of
these numbers per distance interval was performed, and their sum
gave an estimation of the total number of cells per explant.
Normalization to 100 μmwas necessary due to explant size variations.
For quantiﬁcation of endothelial and acinar cell area on sections,
the regions expressing platelet cell adhesion molecule (PECAM), E-
cadherin (E-cadh) and CPA were selected and scanned with a Zeiss
Mirax Midi ﬂuorescence microscope. Images were transferred and
analysed with the Zeiss Axiovision Rel 4.7 program, as follows: the
pancreas, or a particular region within the pancreas, was delineated
on the image and the percentage of the surface occupied by the blue,
green or red signal in the selected region was quantiﬁed.
Cell sorting
Epithelial and non-epithelial cells from Pdx1-GFP pancreata
(e14.5) were sorted based on their ﬂuorescence. GFP/GFP males
were mated with CD1 females and 25 GFP-expressing pancreata were
microdissected at e14.5. Tissue dissociation was performed in 500 μl
of trypsin 0.05% (Gibco) at 37 °C for 10 minutes, with pipet mix every
2 minutes. Reaction was stopped with 500 μl of RPMI+10% Serum
and cellular clumps were removed by passing the cell suspension on a
40-μm nylon ﬁlter (Cell Strainer, BD Falcon). The ﬁlter was washed
once with 1 m of RPMI and the single-cell suspension (2 ml) was
sorted on a FACSVentage (Becton Dickinson).
Real-time RT-PCR
Total RNA was extracted from cultured pancreatic tissues or from
FACS-sorted cells using Trizol reagents (Invitrogen, Carlsbad, CA). RNA
(0.5–1 μg) was reverse-transcribed with random hexamers using
Moloney murine leukemia virus reverse transcriptase (Invitrogen,
Carlsbad, CA). Real-time quantitative PCR was performed in duplicate
by using SYBR Green Supermix (Invitrogen, Carlsbad, CA). Primers
sequences are described in Supplementary Table 2. The relative changes
in target gene/β-actin mRNA ratio were determined by transformation
of threshold cycles to absolute mRNA numbers (Pierreux et al., 2006).
Results
A network of blood vessels embraces the developing
pancreatic epithelium
To investigate the role of blood vessels in pancreas development, we
ﬁrst determined their spatial organization in relation to the pancreatic
epithelium (Fig. 1). At e11.5, when the pancreas consists of a mass of
epithelial cells (labeled for E-cadherin expression), endothelial cells
(detected by PECAM staining) formed an irregular network all around
the tissue bud, as visualized by serial sections analysis (Fig. 1A). At e13.5
and e15.5, the vessels had adopted a honeycomb pattern with
endothelial cells encircling the base of nascent epithelial branches, as
shown by confocal projections; epithelial bulges protruded across the
endothelial network forming branch tips that were at some distance
from the endothelial cells (Fig. 1A). Thesemorphogenetic changeswere
faithfully recapitulated in vitro. Indeed, pancreatic explants isolated at
e12.5 and further cultured for 1 day on a ﬁlter showed the sametopological relationship, with tip cells expressing CPA bulging out of the
epithelium across the network of endothelial cells (Fig. 1B and
Supplementary Fig. 1). Therefore, during pancreas morphogenesis, the
endothelial cells initially surround the epithelial mass of the pancreatic
bud, then form a honeycomb network embracing epithelial trunk cells,
while remaining distant from tip cells.
VEGF-A is expressed in the pancreatic epithelium
Since VEGF-A is a major regulator of blood vessel development, we
investigated by in situ hybridization whether the expression pattern
of this growth factor and, VEGFR2, the main VEGF-A receptor,
correlated with the spatial organization of endothelial cells around
the pancreatic epithelium (Fig. 2). Vegfa expression was detected in
the epithelial cells of the pancreatic bud as early as e11.5, while Vegfr2
(also called Flk1), in an adjacent section, revealed a closely apposed
reticular pattern, with no evidence for expression in the pancreatic
epithelium itself (Figs. 2A,B and A′B′). At e13.5, Vegfa expression
became heterogeneous in the pancreatic epithelium, but predominant
in trunk cells, and vanishing in tip cells, with Vegfr2 still restricted to
endothelial cells (Figs. 2CD and C′D′). These observations were
supported by Q-RT-PCR analysis. E14.5 Pdx-1-GFP mice were used to
separate by FACS GFP-positive (pancreatic epithelium) from GFP-
negative (non-epithelial) cells. The enrichment of Pdx-1 and of the
epithelial marker E-cadherin, and their near absence in the non-
epithelial fraction (GFP-), demonstrated the cell sorting efﬁciency. In
the non-epithelial cells, the expression of VEGFR2 was enriched to the
same proportion as the endothelial marker VE-cadherin, and the
mesenchymal marker FGF-10, indicating lack of epithelial expression
of VEGFR2 (Fig. 2E). Similar ﬁndings were made for VEGFR1 and
VEGFR3. To better visualize the distance between tip cells and
endothelial cells, adjacent sections from an e15.5 pancreas were
costained with either Vegfa or Vegfr2 and the tip/acinar cell marker
CPA (Figs. 2F and F′). Vegfa staining was predominantly found in the
trunk epithelial cells but not in the CPA-positive tip cells. Endothelial
cells, detected by Vegfr2 labeling, were mainly found adjacent to the
trunk epithelial cells, at a distance from the tip cells. Similarly when
e12.5 pancreatic explants were cultured for 2 or 3 days on ﬁlters, a
similar expression proﬁle was observed: epithelial trunk cells were in
close proximity of endothelial cells, whereas tip cells were more
distant (Figs. 2 G, G′ and G″). We concluded that VEGF-A expression is
regionalized during branching morphogenesis and that the predom-
inant expression of VEGF-A in trunk cells correlates well with the
predominant location of endothelial cells near the trunk cells, at a
distance from the tip cells. The expression pattern of VEGFR2 also
suggested that VEGF-A signaling was targeting pancreatic endothelial,
not epithelial cells.
Epithelium-derived VEGF-A controls blood vessel and acinar
development in vivo
To test for a role of VEGF signaling and blood vessel development on
pancreatic differentiation, we performed loss- and gain-of-function
experiments in vivo.Weﬁrst inhibited VEGF-A production by pancreas-
speciﬁc inactivation of ﬂoxed Vegfa alleles. To this end, Pdx1-Cre mice,
which express Cre recombinase exclusively in the pancreatic epitheli-
um, from e11.5 onwards, were mated with Vegfa-loxP mice. Embryos
with homozygous pancreas-speciﬁc inactivation of theVegfa allelewere
analysed at e15.5 (Pdx1-Cre;Vegfa-loxP)(Gerber et al., 1999; Gu et al.,
2002). The recombination efﬁciency was evaluated by in situ hybrid-
ization with the Vegfa probe (Figs. 3A, B): in Pdx1-Cre;Vegfa-loxP
embryos, VEGF-A staining was decreased to background levels
throughout the epithelium, indicating that Cre-mediated recombination
of the Vegfa-loxP alleles was effective. However, some expression of
VEGF-A persisted locally, which indicates that Cre-mediated inactiva-
tion of the Vegfa-loxP alleles was mosaic. The reduction of VEGF-A
Fig. 1. A dense network of blood vessels surrounds the developing pancreatic epithelium. (A) In vivo: immunolabeling of serial sections of control pancreas from e11.5 embryos. At
the initial pancreatic bud stage (e11.5), endothelial cells (PECAM+) surround the epithelial cell mass (E-cadh+). During branching morphogenesis at e13.5 and e15.5, the
endothelial cells adopt a honeycomb pattern intertwined with epithelial outgrowths and are predominantly located near trunk cells, at a distance from the tip cells, as shown by
confocal projections. (B) Explants: a similar relation between endothelial and epithelial cells is found when e12.5 pancreatic explants are cultured for 24 h. The bulging branch tips
identiﬁed by CPA (white arrowheads) outgrow endothelial cells in an adjacent section. Scale bars=50 μm.
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as revealed by the punctate pattern of PECAM staining in sections
(Figs. 3E, E′, F, F′), and three-dimensional reconstruction using
multiphoton microscopy (Figs. 3C, D). Moreover, quantiﬁcation of
the endothelial area on sections conﬁrmed the overall reduction in
blood vessel density in mutant embryos: the endothelial cell area was
12.1±1.0% of total section area (mean±SEM, n=9) in wild-type
pancreas and 6.9±0.3% in mutants (n=14; pb0.001). However,
hypoplasia of the endothelial network was uneven, in line with the
mosaic inactivation of Vegfa-loxP, decreasing locally to a vessel density
down to 1/3 of normal values (3.8±0.4%; n=14; pb0.001) (Fig. 3F′).
Our initial observations of the Pdx1-Cre;Vegfa-loxP mice sug-
gested that acinar development might be affected. Therefore, sections
were immunostained to detect the acinar differentiation markers
CPA and amylase. The results were quantiﬁed by measuring the area
of acinar marker expression, normalized for that of the epithelial
marker E-cadh. No signiﬁcant effect on overall acinar differentiation
was monitored in Pdx1-Cre;Vegfa-loxP pancreata (CPA/E-cadh
ratio=83.4±3.8; mean±SEM; n=14) as compared to controls
(CPA/E-cadh ratio=86.7±4.9; n=9; NS), despite the global reduc-
tion in blood vessel density. However, in selected regions with lowest
vessel density acinar differentiation signiﬁcantly increased (CPA/E-
cadh ratio=93.6±4.5; n=14; pb0.004). This was also monitored bymeasuring the Amy/E-cadh ratio, which was 82.2±5.2 in selected
areas of the transgenic pancreata as compared to 68.9±4.6 in total
pancreas (n=14; pb0.008), pointing to the possibility that endothe-
lial cells repress acinar differentiation (Fig. 3H).
We then generated gain-of-function transgenic embryos over-
expressing VEGF-A in the tip cell region (Ptf1a5'enh/Ela1p-Vegfa).
Expression of the transgene was analysed by in situ hybridization at
e15.5 (Figs. 3I, I′). Four embryos expressed high levels of Vegfa in most
of the tip cells. To visualize blood vessels, the Vegfr2 probe was
hybridized on adjacent sections. This revealed a dramatic change in
the organization of the blood vessels in the pancreas of the 4
transgenic embryos. In addition to their normal localization around
trunk cells, blood vessels now surrounded the Vegfa-expressing acini,
demonstrating that endothelial cell localization depends on VEGF-A
expression pattern (Figs. 3 I, I′). Pancreatic differentiation was then
analysed in these hypervascularized transgenic pancreata. Although
acinar structures were formed at the extremities of the pancreatic
epithelium, we observed a massive reduction of amylase staining
(Figs. 3K, K′). Expression and localization of Ngn3 and of insulin was
normal in the transgenic pancreata at e15.5 (not shown). These data
indicate that epithelium-derived VEGF-A dictates endothelial cell
recruitment and localization, and that in turn blood vessels repress
acinar differentiation.
Fig. 2. Epithelial trunk cells express VEGF-A and recruit VEGFR2+ endothelial cells. (A–D) In vivo: In situ hybridization on two serial e11.5 embryo sections show expression of Vegfa
in the pancreatic bud (yellow dotted line), and Vegfr2 in endothelial cells around the bud (A, A′, B, B′). At e13.5 (C, C′, D, D′), Vegfa shows a higher expression in the trunk cells
(red dotted line) as compared to the epithelial outgrowths (yellow dotted line). (E) Vegfrs are expressed in the non-epithelial (FACS-sorted GFP−) cell population enriched in VE-
cadherin and FGF-10 and depleted in E-cadherin and Pdx1. (F,F') In vivo: In situ hybridization coupled to immunohistochemistry on two serial e15.5 embryo sections show
expression of CPA (brown) at a distance of epithelial trunk (Vegfa; blue) and endothelial (Vegfr2; blue) cells. (G,G′,G″) Explants(3 serial sections): A similar expression pattern of
Vegfa and Vegfr2 is found in e12.5 pancreatic explants cultured for 48 h. Trunk cells (red dotted line), highly expressing Vegfa, are surrounded by Vegfr2+cells. The epithelial
outgrowths (yellow dotted line), selectively express CPA. Scale bars in A–D=1000 μm; in A′–D′=100 μm; in F, G, scale bar=50 μm.
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VEGF-A signaling
To further investigate the role of endothelial cells during pancreas
development, we studied pancreatic explants, as these could be
treated with recombinant VEGF-A or the VEGFR signaling inhibitor,
SU5416. When e12.5 pancreatic explants were cultured for 2 days inthe presence of SU5416 endothelial cells disappeared (E-cad/PECAM
labeling; Figs. 4A, A′, B, B′). This effect involved apoptosis as suggested
by the activation of caspase-3 (Fig. 4G). Likewise, oxindole and
PTK787, two unrelated VEGFR2 inhibitors caused disappearance of
PECAM expression (Supplementary Fig. 2). Conversely, addition of
VEGF-A to the culture medium increased the density of endothelial
cells (Fig. 4C′) in a concentration-dependent manner (Supplementary
Fig. 3. VEGF-A modulation affects endothelial cell development and acinar differentiation. (A, B) In situ hybridization shows reduced expression of Vegfa in e15.5 Pdx1-Cre;Vegfa-
loxP (Vegfa-ﬂ/ﬂ) pancreas, as compared to controls. (C–F) Blood vessel density is reduced in Pdx1-Cre;Vegfa-loxP pancreas, as revealed by three-dimensional reconstructions of the
endothelial network (C, D) and by punctate immunoreactivity for PECAM on (E, F) selected regions of the pancreas (E, E′, F, F′). (G, H) Increased CPA immunolabeling in selected
region of Pdx1-Cre;Vegfa-loxP pancreas. (I, J) In situ hybridization shows increased expression of Vegfa in the tip cells of e15.5 Ptf1a-Ela/Vegfa pancreas (I′), and the associated
increase in endothelial cell density around the tips (J′), as compared to controls (I, J). (K, K′) Reduced amylase immunolabeling in Ptf1a-Ela/Vegfa transgenic pancreas. Scale bars in
A, B, E, F=200 μm; in C, D, E′, F′, G–K=100 μm.
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endothelial marker VE-cadherin was affected within 12 h of treat-
ment (Fig. 4H). The pancreatic epithelium was also strongly affected
by the addition of SU5416 or of VEGF-A, which respectively led to
fewer but larger epithelial buds, or less densely packed epithelium
(Figs. 4A–C). Confocal analysis of explant sections conﬁrmed the
absence of endothelial cells in the SU5416-treated culture and their
increase in VEGF-A-treated explants (Figs. 4D–F). Moreover, in
explants treated with VEGF-A, the epithelium became almost
completely trapped in the endothelial network. Taken together,
these results indicated that VEGF signaling regulates the number of
endothelial cells and their spatial relationship with the pancreatic
epithelium.Endothelial cells regulate pancreatic cell differentiation
We next examined the expression of acinar differentiation
markers in explants in which endothelial development has been
modulated. In SU5416-treated explants, i.e. in the absence of
endothelial cells, the number of CPA+cells and of Ptf1a+cells was
increased after 2 days of treatment (Figs. 5A, B). This increase was
restricted to the epithelial outgrowths and was not observed in trunk
cells (Fig. 5A). Since CPA and Ptf1a are markers of both pluripotent tip
cells and acinar cells, we further assessed the expression of the acinar-
speciﬁc marker amylase. As shown in Fig. 5A, CPA+cells also
expressed amylase and thus corresponded to acinar cells. As
predicted, treating explants with VEGF-A, which induced endothelial
Fig. 4.Modulation of VEGF-A signaling in explants affects endothelial cell density. (A–F) Immunolabeling of whole-mounts (A, A′–C, C′) and sections (D–F) of e12.5 explants cultured
for 48 h shows either absence or increased density of blood vessels when VEGF-A signaling is inhibited by SU5416 or stimulated by VEGF-A, respectively. (G) A 4-hour treatment
with SU5416 induces endothelial cell apoptosis (cleaved caspase-3; green). (H) Treatment with SU5416 decreases, while addition of VEGF-A stimulates VE-cadherin expression in
cultured explants, as measured by Q-PCR (*pb0.05 by t test).
222 C.E. Pierreux et al. / Developmental Biology 347 (2010) 216–227cell development, had effects opposite to those of SU5416, as shown
by decreased expression of CPA and amylase (Fig. 5C). In line with our
in vivo observations, these data indicated that a reduction in
endothelial cell numbers promotes acinar development, whereas an
increase represses acinar differentiation.
To get insight into the mechanism by which endothelial cells
repress acinar differentiation, we monitored gene expression in
cultured explants by Q-RT-PCR (Figs. 5D, E). Inhibition of VEGF-A
signaling by SU5416, which rapidly inhibited endothelial develop-
ment (see Fig. 4B), induced concomitantly the expression of Ptf1a,
RBP-J and RBP-JL, indicating that the acinar transcriptional program
was rapidly promoted after repression of VEGF-A signaling (Fig. 5D).
Conversely, stimulation of VEGF-A signaling by treatment with VEGF-A induced endothelial development and repressed the expression of
these acinar markers after 24 h: the effect of VEGF-A on acinar
development was thus slightly delayed as compared with the effect of
SU5416 (Fig. 5E). Taken together, these observations indicate that
modulation of VEGF-A signaling in endothelial cells impacts on Ptf1a
expression in the epithelium, more speciﬁcally in the epithelial
outgrowths, and not in central epithelial cells (Fig. 5A). The
expression of Myc, which is required for exocrine development and
is stimulated by Wnt signaling, was not affected by treatment with
SU5416 or VEGF-A (Figs. 5D, E). Similarly, Exdpf, which is required for
exocrine development in Zebraﬁsh, remained unchanged (Figs. 5D, E).
Since Notch signaling is also involved in exocrine differentiation, we
measured the expression of the Notch target genes, Hes-1, Hey-1 and
Fig. 5. Endothelial cells repress acinar differentiation in vitro. (A) Increased immunolabeling of Ptf1a, CPA and amylase in SU5416-treated explants. (B) Quantiﬁcation of Ptf1a+cells
in SU5416-treated explants. (C) Decreased immunolabeling of amylase and CPA after 96 h in the presence of VEGF-A. (D, E) Q-PCR proﬁling in explants cultured for 12 h (D) and
24 h (E). Treatment with SU5416 increases, while VEGF-A decreases the expression of Ptf1a, Rbpj and Rbpjl (*pb0.05 by t test). Treatment with SU5416 decreases the expression
of Hey-1 and Hey-2, while VEGF-A increases that of Hey-1 (*pb0.05 by t test). The expression of Hes-1 (measured at 24 h in D and E), Myc and Exdpf is unaffected. Scale bars in A
and C=50 μm.
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Hes-1 was not affected, but that of Hey-1 and Hey-2 was reduced by
SU5416 and increased by VEGF-A (Figs. 5D, E). Together, these data
suggest that blood vessels control exocrine differentiation by
modulating Ptf1a expression and Notch signaling.
We also investigated whether modulating VEGF-A signaling
affected epithelial cell proliferation or survival. Explants were
cultured for 2 days and proliferation of epithelial cells was visualizedby co-staining for phospho-histone H3 (pHH3) and E-cadh. No
signiﬁcant effect on proliferation was seen in SU5416-treated
explants as compared to controls, whereas treating explants with
VEGF-A reduced proliferation (Supplementary Table 3). The effect of
VEGF-A was not speciﬁc to acinar cells, since the pHH3+/E-cadh
+cells were evenly distributed throughout the epithelium, and not
restricted to epithelial outgrowths (data not shown). The lack of cell-
type speciﬁc proliferation and the inconsistency between the
224 C.E. Pierreux et al. / Developmental Biology 347 (2010) 216–227proliferation rates measured in SU5416- or VEGF-A-treated explants
led us to conclude that proliferation is not essential for VEGF-A-
controlled acinar development. With regard to cell survival, active
caspase-3 staining of sections from control and SU5416-treated
explants showed a very low number of apoptotic cells. This number
increased upon treatment with SU5416 but remained low (Supple-
mentary Table 3). An increase in apoptosis when VEGF-A signaling is
inhibited, cannot explain the concomitant increase in acinar cell
numbers.
The mosaic phenotype of Pdx1-Cre;Vegfa-loxP embryos precluded
a reliable analysis of endocrine differentiation. Indeed, endocrine cells
are much less abundant than acinar cells, and analysis of low numbers
of endocrine cells in selected pancreatic regions could produce biased
data. Endocrine development was thus analysed on pancreatic
explants. The proendocrine marker, Ngn3, was readily immunola-
beled in the nuclei of trunk cells in control conditions but had almost
vanished after 2 days in the presence of SU5416 (Fig. 6A). The number
of cells expressing the late endocrine marker Pax6 was also reduced,
further supporting that SU5416 inhibits endocrine differentiation
(Fig. 6A). Surprisingly, VEGF-A did not stimulate endocrine differen-
tiation, since expression of Ngn3 and Pax6 remained unchanged
(Fig. 6B). The number of Ngn3+ cells in control explants (182.9±
67.2) was not statistically different from that in VEGF-A-treated
explants (148±8.1). These data suggested that endothelial cells were
required but not sufﬁcient to induce endocrine differentiation in
cultured explants.
Sox9 marks a progenitor population and is essential for endocrine
but not for exocrine development (Seymour et al., 2008; Seymour
et al., 2007). At e12.5 in vivo, Sox9 expression is expressed throughout
the epithelium, including in tip and trunk cells (Zhou et al., 2007).Fig. 6. Endothelial cells are required for endocrine differentiation in vitro. (A) Treatment
expansion of Pax6+cells. (B) Addition of VEGF-A does not affect Ngn3 and Pax6 immunolabe
immunolabeling (D) (*pb0.05 by t test). Scale bars in B and D=50 μm.Later, it becomes restricted to centrally located epithelial cords
(Seymour et al., 2007). This was also the case in cultured explants
(Fig. 6D). Treatment of explants with SU5416, signiﬁcantly decreased
Sox9 mRNA levels after 24 h (Fig. 6C). By immunoﬂuorescence, Sox9
labeling was also decreased in both epithelial outgrowths and trunk
cells (Fig. 6D). Treatment with VEGF-A did not affect signiﬁcantly the
expression of Sox9 (data not shown). These data suggest that VEGF-A
signaling is required but not sufﬁcient for Sox9 expression. Consid-
ering that the SU5416-mediated repression of Ngn3 and Sox9 occurs
simultaneously and is restricted to trunk cells, we suggest that VEGF-
A signaling in endothelial cells is required to maintain the Sox9+
progenitor pool and its endocrine derivatives. An effect on Ngn3+
cells, independently from Sox9, cannot be excluded.
We conclude that, during pancreatic development, VEGF-A is
secreted by the epithelium and required for recruitment, develop-
ment and function of pancreatic endothelial cells. In return,
endothelial cells signal back to the growing epithelium so as to
repress Ptf1a and exocrine differentiation. Endothelial cells are also
required to maintain the centrally located endocrine progenitors.
Discussion
In the present work, we ﬁrst show how endothelial cells develop
and localize around the pancreatic epithelium during pancreas
development. When the epithelial bud undergoes branching remo-
deling, the endothelial cells become preferentially positioned close to
the trunk cells of the epithelium, while remaining at a distance from
the branch tips where exocrine cells differentiate. The preferential
location of endothelial cells near trunk cells correlates with the
predominant expression of VEGF-A in the latter cells. Inactivation ofof explants with SU5416 decreases the number of Ngn3+ cells and slows down the
ling. (C, D) SU5416 decreases expression of Sox9 in explants as shown by Q-PCR (C) and
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of endothelial cells and increased that of acinar cells. Overexpression
of a Vegfa transgene in the tip cells induced endothelial cell
recruitment around the tips and this decreased acinar differentiation.
Similarly, stimulation of VEGF-A signaling in cultured pancreatic
explants induced endothelial cell development and repressed
acinar development. The opposite effects were seen after inhibition
of VEGF-A signaling. Therefore, our data suggest reciprocal interac-
tions whereby endothelial cells organize as a meshwork in response
to epithelial-derived VEGF-A, and signal back to limit acinar cell
differentiation.
The remodeling of the endothelial network resulting from
inactivation of the Vegfa alleles, or from overexpression of Vegfa
speciﬁcally in the tip cells, indicates that this signaling factor is a key
regulator of the spatial organization of endothelial cells during
pancreas development. Extracellular matrix could also participate in
the regulation of endothelial regionalization. Indeed, we found that
laminin is more abundant near the trunk cells than around the tip
cells. However, treating explants with SU5416 inhibited vessel
development and reduced laminin production near the trunk cells,
thereby abolishing the difference in laminin deposits between the tip
and trunk areas (data not shown). Considering that the laminins
around β-cells of the islets of Langerhans are produced by the
endothelial cells (Nikolova et al., 2006), we suggest that VEGF-A
production is the causal event regulating endothelial organization and
that extracellular matrix regionalization is a consequence of endo-
thelial cell localization.
Transcription factors or regulators determining regionalized Vegfa
expression remain to be identiﬁed. VEGF-A's predominant location in
trunk cells rather than in epithelial outgrowths may result from
differential oxygenation of the epithelial cells. Indeed, a key inducer of
VEGF-A expression is hypoxia-induced factor-1, and the latter is
predominantly expressed in epithelial trunk cells (http://www.
genepaint.org/) while progressively decreasing during development
(Heinis et al., 2009). Therefore, we speculate that when the
epithelium remodels into a ramiﬁed structure, the less oxygenated
cells express Hypoxia-Induced Factor-1 and VEGF-A, and stimulate
endothelial development in their close proximity until a sufﬁcient
oxygenation level is reached. Our analysis of FACS-sorted epithelial
and non-epithelial cells indicated that the VEGF receptors were
expressed in the non-epithelial compartment andwere not detectable
at signiﬁcant levels in the epithelium. Consequently, the close
proximity between epithelial trunk cells and the endothelial mesh-
work is optimal for a reciprocal interaction, and the epithelial
phenotype induced by modulation of VEGF-A signaling should result
from an indirect effect. We therefore propose that the epithelium
controls the development and the spatial organization of the
endothelial cells through localized (i.e. by trunk cells) secretion of
VEGF-A, and that the endothelial cells signal back to the adjacent
epithelial cells by means of an as yet unidentiﬁed signaling
mechanism to control epithelial differentiation.
The role of endothelial cells was investigated in vivo as well as in
cultured explants. In these explants, gain- or loss-of-function experi-
ments could be performed by adding VEGF-A or the pharmacological
inhibitor SU5416 to the culture medium. Arguably, SU5416 not only
inhibits VEGFR2, the main receptor for VEGF-A, but also the platelet-
derived growth factor receptor. However, at the concentration used
(5 μM), SU5416 preferentially targets VEGFR2 (IC50=1 μM) than the
platelet-derived growth factor receptor (IC50=20 μM). Moreover,
oxindole and PTK787, two other VEGFR2 inhibitors, reproduced the
effects of SU5416 on endothelial development and on expression of
Ptf1a and CPA. In contrast, neither Glivec, a PDGFR inhibitor, nor PDGF
itself modulated Ptf1a expression (not shown). We are conﬁdent that
the acinar phenotype induced by SU5416 results from an inhibition
of VEGFR2 since these effects were opposite to those of VEGF-A.
Moreover, the results obtained in cultured explants on acinardevelopment are in line with those obtained with genetic approaches
in vivo.
Our data indicate that endothelial cells repress acinar differenti-
ation. This is coherent with the preferential location of the endothelial
cells at a distance from the acinar cells and suggests that endothelial
cells exert their repressive effect by means of a (or several) secreted
factor(s). The latter would either fail to reach the branch tips or would
diffuse along a gradient generating high, repressive concentrations
near the trunk cells, and low, permissive concentrations near the
branch tips. According to this interpretation, excessive endothelial
development as a result of treatment with VEGF-A would repress
acinar development by two, non-mutually exclusive mechanisms.
First, the presence of endothelial cells near the branch tips would
reduce the diffusion distance of the secreted factor which then
reaches the branch tips at high concentrations. Second, an overall
increase in secreted factor would result from the increase in the
number of endothelial cells that produce this factor. This implies the
need for a tight control of the number and location of endothelial cells,
as well as of the timing of their development. Indeed, repression of
endothelial development in explants treated with SU5416 did not
induce acinar differentiation of all the pancreatic cells. Still, we noted
that the acinar buds (Ptf1a+or CPA+; see Fig. 5A) in SU5416-treated
explants were larger than those in control explants. Since there is no
increase in proliferation, this suggests that trunk cells close to the tip
cells had been diverted from their ductal/endocrine fate towards the
acinar fate. The rest of the epithelial trunk cells would already be
committed to ductal or endocrine differentiation and could not revert
their phenotype to the acinar lineage.
The identity of the downstream effectors of endothelial signaling
remains unknown. Three candidates do not appear to qualify (Wnt,
Exdpf, epithelial–mesenchymal contact), but Ptf1a and Notch signal-
ing are likely candidates. First, our data do not favor the involvement
of Wnt signaling in the endothelium-mediated control of exocrine
development since the expression of the Wnt target gene Myc was
unaffected in our experiments. Second, Exdpf is a signaling mediator
identiﬁed as a key regulator of exocrine development in the zebraﬁsh;
its expression was not affected in our experiments with mouse
explants. Third, whereas increased contact between epithelium and
mesenchyme promotes duct and acinar differentiation (Crisera et al.,
2000; Duvillie et al., 2006; Li et al., 2004; Miralles et al., 1998), VEGF-A
reduced the packing of the epithelium, thereby facilitating interac-
tions between the epithelium andmesenchyme (Fig. 4). However, this
is associated with repression of acinar differentiation, eliminating the
possibility that VEGF-A controls acinar differentiation by regulating
interactions between the epithelium and mesenchyme. Conversely,
stimulation of VEGF-A signaling and endothelial development
repressed Ptf1a expression. In contrast, expression of Ptf1a was
upregulated when VEGF-A signaling and endothelial development
were inhibited. Since there was no evidence for a speciﬁc increase in
exocrine cell proliferation that might explain the increase in Ptf1a
mRNA levels and in the number of Ptf1a+cells, our data suggest that
Ptf1a expression in progenitor cells is the target of endothelial
signaling. Our data further suggest an additional mechanism that
regulates Ptf1a function. Indeed, treating explants with VEGF-A or
SU5416 showed that endothelial development is associated with
induction of Hey1 and Hey2. These are Notch signaling effectors
known to repress Ptf1a activity (Esni et al., 2004). Therefore,
endothelial signaling might repress acinar differentiation by repres-
sing expression and activity of Ptf1a. Our data do not rule out the
possibility that endothelial cells signal to mesenchymal cells which
would serve as a relay to mediate effects on the epithelium. In
collaboration with K. Zaret's team, our group has proposed the
existence of such a relay pathway at the onset of pancreas
morphogenesis. At this stage, endothelial cells promote survival of
mesenchymal cells, which secrete factors that control pancreas
morphogenesis and maintain pancreatic differentiation (Jacquemin
226 C.E. Pierreux et al. / Developmental Biology 347 (2010) 216–227et al., 2006). Interestingly, at the stage of pancreas speciﬁcation,
aortic endothelial cells induce Ptf1a expression in the adjacent
endoderm (Yoshitomi and Zaret, 2004), suggesting that aortic cells
and pancreatic endothelial cells have opposite functions on Ptf1a
expression.
Our in vitro experiments also suggested a role for VEGF-A signaling
in endocrine development. Previous work has shown that endothelial
cells can initiate endocrine differentiation at an early stage of pancreas
development (Lammert et al., 2001). Addition of VEGF-A to e12.5
explants or overexpression of VEGF-A in tip cells in vivo did not
stimulate endocrine development at e15.5. However, inhibiting VEGF-
A signaling in vitro with SU5416 reduced endocrine differentiation,
suggesting that VEGF-A signaling and endothelial cells are required
but not sufﬁcient for endocrine development. Unfortunately, the
mosaic phenotype of Pdx1-Cre/Vegfa-loxP embryos did not allow to
reliably evaluate their endocrine phenotype. Since the endocrine
compartment represents but a minor fraction of the total pancreas
(5%), any selection of affected regions, as performed for the analysis of
the exocrine compartment, could generate biased data.
The lack of endocrine stimulation in response to additional VEGF-A
and endothelial cell signaling could be explained if all progenitor
cells were maximally stimulated by the abundant endothelial
cells already present in control conditions. In addition, the number of
Sox9-expressing progenitors was decreased in the presence of
SU5416, suggesting that endothelial cells may control this progenitor
cell type. The reduction in Sox9+ cells may lead to the observed
decrease in Ngn3+ progenitors since lineage tracings have demon-
strated that Sox9+ cells give rise to Ngn3-expressing cells (Seymour
et al., 2007). A word of caution is needed with regard to the use of
pharmacological inhibitors, since we cannot formally eliminate the
possibility that they can induce non-speciﬁc effects on endocrine
development. Using VEGFR2 blocking antibodies or soluble VEGFR2 in
explant cultures did not allow to obtain strong reduction of endothelial
development, thereby preventing further analysis of pancreas differen-
tiation. Despite this limitation, the observation that endothelial cells
may sendsignals required formaintenance andexpansionof Sox9+and
Ngn3+ cells seems of importance for in vitro programmed differenti-
ation towards cell therapy of diabetes.
In conclusion, cross-talk between the pancreatic epithelium and
the endothelial cells controls the number and spatial organization of
the endothelial network closely intertwined around the epithelial
branches. This interplay is necessary for appropriate differentiation of
acinar cells. In vitro observations further suggest that endothelial cells
may also be required to maintain endocrine progenitors.
Supplementary data to this article can be found online at
doi:10.1016/j.ydbio.2010.08.024.
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